NIH-funded research Career grant

Enhancing brain metastases care with clear AI insights

Official title: Enhancing precision medicine for brain metastases using interpretable and integrative deep learning

Funded at Massachusetts General Hospital · NIH-11332763 · Data updated 2026-11-12

A physician-scientist at MGH will use interpretable deep learning to understand why brain metastases resist treatment and how to tailor therapy for patients.

More Deep Learning research and trials

Quick facts

Grant typeCareer grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startAugust 1, 2025
Project endJuly 31, 2029
Funding year2026
Award (this year)$193,856
NIH project number5K08EB037077-02
Project IDNIH-11332763 on NIH RePORTER

Who could benefit from this research

Could help

Patients with brain metastases or solid tumors under treatment who may benefit from personalized therapy approaches.

Less likely to help

Patients without access to the necessary imaging/genomic data or those not eligible for the targeted therapies being studied.

What this research studies

This grant supports a clinician who wants to move toward independent work by combining cancer genomics, imaging, and deep learning to personalize treatment for brain metastases. The project emphasizes translational work, mentorship from leaders in DL, and collaboration with top institutions to apply AI to real patient data. The goal is to generate clinically meaningful insights that could guide therapies for cancer patients with brain metastases. Training focus includes building practical DL skills and integrating multi-modal clinical information to inform decisions. The work will stay closely connected to patient care and early-phase clinical trial insights at MGH and affiliated centers.

Why it matters

Potential benefit: If successful, patients with brain metastases could receive more personalized and effective treatment strategies guided by AI-derived patterns.

How similar studies have gone: Prior work in DL for cancer has shown promise, but this project aims to advance interpretable methods and direct clinical applicability in brain metastases.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Kim, Albert — Massachusetts General Hospital
  • Study coordinator: Kim, Albert

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.